Centessa Pharmaceuticals PLC ADR
Price & Volume
Stats
See more52W Range | $9.60-$19.09 |
Market Cap | $2.2B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $15M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $15M |
Diluted EPS | -$1.85 |
News
See moreYahoo Finance • 4 days ago
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025
Yahoo Finance • 17 days ago
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ...
Yahoo Finance • 20 days ago
Centessa Pharma (CNTA) CBO Weinhoff sells $155,598 in shares
Yahoo Finance • 25 days ago
Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.
About
CEO | Dr. Saurabh Saha M.D., Ph.D. |
CFO | Mr. John J. Crowley CPA |
Address | 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 98 |
